A clinical trial of a potential Ebola therapy, led by Oxford University, has got under way in Sierra Leone.
The phase II study of the treatment, called TKM-Ebola-Guinea, led by Oxford's Professor Peter Horby on behalf of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), is funded through the Wellcome Trust's £3.2 million Ebola therapeutics platform.
Book tickets to hear Professor Adrian Hill speak on vaccines for Ebola and Malaria – Thursday 23 April at 6pm